Chemring Grp Plc Unsp/Adr (CMGMY) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

And welcome... to the presentation of Kemring's interim results for the six months to the 30th of April, 2025. I am, as usual, joined by our CFO, James Mortenson. I'll briefly cover some of the group highlights from our first half before handing over to James, who'll take you through our financial and operational performance. I'll then comment on the general market environment and the progress we are making in delivering our incremental growth strategy, which is underpinned by our values of safety, excellence, and innovation. We'll then take questions. Our momentum from 2024 has been maintained into this year with the continued delivery of our long-stated goal of balancing near-term performance with longer-term growth and value creation. Across the first half, our operational and trading performance has been robust and in line with the expectations we set out in December, continuing to demonstrate the resilience and quality of the group. Our record order book and associated trading visibility underpins our growth ambitions as we build towards our goal of increasing annual revenue to £1 billion by 2030 and be assured we will continue to closely manage operational and financial risk during this period of organic and inorganic growth. In summary, the Board's expectations for the full year are unchanged. Clearly, none of this is possible without the commitment and dedication of my colleagues across the group, and I want to take this opportunity to acknowledge and thank them all for their unrelenting professionalism and hard work. Turning to the headline numbers, for me the standout is our record £488 million of order intake, which is a 42% increase from last year, and the resulting £1.3 billion order book, which is the highest in the company's history. Operationally, our...